Steven Cohen Immunome Inc. Call Options Transaction History
Point72 Asset Management, L.P.
- $40.1 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IMNM
# of Institutions
145Shares Held
66MCall Options Held
47.3KPut Options Held
4.31M-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.55MShares$61.6 Million0.03% of portfolio
-
Redmile Group, LLC San Francisco, CA5.36MShares$43.7 Million3.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.31MShares$35.1 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.08MShares$33.3 Million2.16% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$30.7 Million0.0% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $99M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...